MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Chang, Shing Jyh ^a,b   Weng, Shun Long ^a   Hsieh, Jui Yu ^c   Wang, Tao Yeuan ^a,d   Chang, Margaret ^b   Wang, Hsei Wei ^c,e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 137; MICRORNA 138; MICRORNA 160A; MICRORNA 17 5P; MICRORNA 206; MICRORNA 20A; MICRORNA 20B; MICRORNA 323; MICRORNA 345; MICRORNA 34A; MICRORNA 368; MICRORNA 374; MICRORNA 377; MICRORNA 424; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN;

ARTICLE; BINDING SITE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NUCLEOTIDE METABOLISM; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; UMBILICAL CORD; WHARTON JELLY MATRIX; ACTIN FILAMENT; CELL MOTION; CYTOLOGY; FETUS BLOOD; GENETICS; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT;

ACTIN CYTOSKELETON; BINDING SITES; CELL MOVEMENT; CELL TRANSDIFFERENTIATION; ENERGY METABOLISM; FETAL BLOOD; HUMANS; MESENCHYMAL STEM CELLS; MICROARRAY ANALYSIS; MICRORNAS; NEUROGENESIS; NEURONS; OXIDATIVE PHOSPHORYLATION;

EID: 80052831075     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-65     Document Type: Article

References (34)

1. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D, Stem Cells 2006 24 3 781 792 10.1634/stemcells.2005-0330 16223852 (Pubitemid 44464783)
2. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, Su CY, Li H, Neurobiol Dis 2007 27 3 339 353 10.1016/j.nbd.2007.06.010 17651977 (Pubitemid 47337188)
3. Stem cells and aging: expanding the possibilities. Rao MS, Mattson MP, Mech Ageing Dev 2001 122 7 713 734 10.1016/S0047-6374(01)00224-X 11322994 (Pubitemid 32378722)
4. Matrix cells from Wharton's jelly form neurons and glia. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, et al. Stem Cells 2003 21 1 50 60 10.1634/stemcells.21- 1-50 12529551 (Pubitemid 36120365)
5. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 7 1330 1337 10.1634/stemcells.2004-0013 15579650 (Pubitemid 39636408)
6. Transformation of human umbilical mesenchymal cells into neurons in vitro. Fu YS, Shih YT, Cheng YC, Min MY, J Biomed Sci 2004 11 5 652 660 10.1007/BF02256131 15316141
7. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. Bertani N, Malatesta P, Volpi G, Sonego P, Perris R, J Cell Sci 2005 118 Pt 17 3925 3936 16091422 (Pubitemid 41410276)
8. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS, Stem Cells 2006 24 1 115 124 10.1634/stemcells.2005-0053 16099997
9. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS, PLoS ONE 2008 3 10 3336. 18852872
10. Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Wang TT, Tio M, Lee W, Beerheide W, Udolph G, Biochem Biophys Res Commun 2007 357 4 1021 1027 10.1016/j.bbrc.2007.04.046 17466951 (Pubitemid 46693673)
11. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 7027 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
12. The impact of microRNAs on protein output. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP, Nature 2008 455 7209 64 71 10.1038/nature07242 18668037
13. Widespread changes in protein synthesis induced by microRNAs. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N, Nature 2008 455 7209 58 63 10.1038/nature07228 18668040
14. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T, et al. Cancer Sci 2007 98 12 1845 1852 10.1111/j.1349-7006.2007.00619.x 17888029 (Pubitemid 350002188)
15. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X, Cancer Lett 2009 275 1 44 53 10.1016/j.canlet.2008.09.035 19006648
16. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R, Cell Cycle 2010 9 6 1031 1036 10.4161/cc.9.6.10987 20190569
17. MicroRNAs in cancer-from research to therapy. Cho WC, Biochim Biophys Acta 2010 1805 2 209 217 19931352
18. microRNA, cell cycle, and human breast cancer. Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG, Am J Pathol 2010 176 3 1058 1064 10.2353/ajpath.2010.090664 20075198
19. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Cho WC, Int J Biochem Cell Biol 2010 42 8 1273 1281 10.1016/j.biocel.2009.12.014 20026422
20. MicroRNAs and cancer stem cells. Yu Z, RG P, MicroRNAs in cancer translational research, Cho WC, 2011 373 388
21. MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Greco SJ, Rameshwar P, Proc Natl Acad Sci USA 2007 104 39 15484 15489 10.1073/pnas.0703037104 17855557 (Pubitemid 47502943)
22. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW, Stem Cells Dev 2010 19 12 1895 1910 10.1089/scd.2009.0485 20367285
23. The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. Tsai YH, Wu MF, Wu YH, Chang SJ, Lin SF, Sharp TV, Wang HW, J Virol 2009 83 2 622 632 10.1128/JVI.00869-08 18971265
24. Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Huang TS, Hsieh JY, Wu YH, Jen CH, Tsuang YH, Chiou SH, Partanen J, Anderson H, Jaatinen T, Yu YH, et al. Stem Cells 2008 26 5 1186 1201 10.1634/stemcells.2007- 0821 18308945
25. ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Yang TP, Chang TY, Lin CH, Hsu MT, Wang HW, Bioinformatics 2006 22 21 2697 2698 10.1093/bioinformatics/btl457 16935928 (Pubitemid 44642613)
26. Adult bone marrow stromal cells differentiate into neural cells in vitro. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, et al. Exp Neurol 2000 164 2 247 256 10.1006/exnr.2000.7389 10915564 (Pubitemid 32008970)
27. Identification of genetic networks during mesenchymal stem cell transformation into neurons. Chou SC, Ko TL, Fu YY, Wang HW, Fu YS, Chinese Journal of Physiology 2008 51 4 230 246 19112881
28. The Gene Ontology (GO) database and informatics resource. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, et al. Nucleic Acids Res 2004 32 Database 258 261
29. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Cho KJ, Trzaska KA, Greco SJ, McArdle J, Wang FS, Ye JH, Rameshwar P, Stem Cells 2005 23 3 383 391 10.1634/stemcells.2004-0251 15749933 (Pubitemid 40404457)
30. Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. Montzka K, Lassonczyk N, Tschoke B, Neuss S, Fuhrmann T, Franzen R, Smeets R, Brook GA, Woltje M, BMC Neurosci 2009 10 16 10.1186/1471-2202-10-16 19257891
31. The miR-34 family in cancer and apoptosis. Hermeking H, Cell Death Differ 2010 17 2 193 199 10.1038/cdd.2009.56 19461653
32. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et al. Nat Med 2011 17 2 211 215 10.1038/nm.2284 21240262
33. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S, Russo T, Faseb J 2010 24 9 3255 3263 10.1096/fj.09-152207 20439489
34. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, Lieberman J, Blood 2009 114 10 2181 2192 10.1182/blood-2009-02- 205062 19584398